At Scimia Consulting, we focus on colorectal cancer and other chronic diseases, designing predictive algorithms for early detection and triage of patients with a positive Fecal Immunochemical Test or Fecal Occult Blood Test. Our aim is to reduce the burden of colonoscopies that currently weigh on colorectal cancer screening programs. We developed both fully virtual tests and an algorithm that needs to be combined with a molecular test. Our products are validated on clinical datasets, derived from real screening programs, with 1300 subjects.
We developed an algorithm that significantly reduces the burden of colonoscopies due to false positives from FIT tests in CRC screenings.
DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Author
Business development manager at Scimia Consulting di Mauro Scimia